If you suffer from knee pain due to a cartilage injury, you may be eligible for a study on new treatments.
- Brian J. Cole, M.D., M.B.A.
- Adam B. Yanke, M.D.
Clinical Trial Protocol Description
This is a clinical investigation of the effect of bone marrow derived mesenchymal stem cells used in the treatment of patients with isolated cartilage lesions undergoing surgical treatment via osteochondral allograft transplantation. The full terms of the investigation are detailed and disclosed in the patient consent form and will be described to patients by the physician or research coordinator upon inquiry. Eligible patients may be contact by either the physician or research coordinator prior to their scheduled surgery.
Clinical Trial Eligibility Criteria
This clinical trial is a new approach to treatment of cartilage lesions with osteochondral allograft transplantation. To be eligible for this study, you must:
- Be between the ages of 18 and 50 years old
- Have a cartilage lesion indicated for treatment with osteochondral allograft transplantation
- Not have a history of knee joint infection or rheumatoid arthritis